246 related articles for article (PubMed ID: 22829600)
1. Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling.
Fekonja O; Benčina M; Jerala R
J Biol Chem; 2012 Sep; 287(37):30993-1002. PubMed ID: 22829600
[TBL] [Abstract][Full Text] [Related]
2. SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.
Carlsson E; Ding JL; Byrne B
Biochim Biophys Acta; 2016 Feb; 1863(2):244-53. PubMed ID: 26592460
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.
Loiarro M; Volpe E; Ruggiero V; Gallo G; Furlan R; Maiorino C; Battistini L; Sette C
J Biol Chem; 2013 Oct; 288(42):30210-30222. PubMed ID: 24019529
[TBL] [Abstract][Full Text] [Related]
4. Salmonella Coiled-Coil- and TIR-Containing TcpS Evades the Innate Immune System and Subdues Inflammation.
Xiong D; Song L; Geng S; Jiao Y; Zhou X; Song H; Kang X; Zhou Y; Xu X; Sun J; Pan Z; Jiao X
Cell Rep; 2019 Jul; 28(3):804-818.e7. PubMed ID: 31315056
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.
Yadav M; Zhang J; Fischer H; Huang W; Lutay N; Cirl C; Lum J; Miethke T; Svanborg C
PLoS Pathog; 2010 Sep; 6(9):e1001120. PubMed ID: 20886104
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.
Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS
J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of bacterial interference with TLR4 signaling by Brucella Toll/interleukin-1 receptor domain-containing protein TcpB.
Alaidarous M; Ve T; Casey LW; Valkov E; Ericsson DJ; Ullah MO; Schembri MA; Mansell A; Sweet MJ; Kobe B
J Biol Chem; 2014 Jan; 289(2):654-68. PubMed ID: 24265315
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
9. Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal).
Bovijn C; Desmet AS; Uyttendaele I; Van Acker T; Tavernier J; Peelman F
J Biol Chem; 2013 Apr; 288(17):12054-66. PubMed ID: 23460645
[TBL] [Abstract][Full Text] [Related]
10. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
[TBL] [Abstract][Full Text] [Related]
11. Suppression of TLR signaling by targeting TIR domain-containing proteins.
Fekonja O; Avbelj M; Jerala R
Curr Protein Pept Sci; 2012 Dec; 13(8):776-88. PubMed ID: 23305364
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling.
Ohnishi H; Tochio H; Kato Z; Orii KE; Li A; Kimura T; Hiroaki H; Kondo N; Shirakawa M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10260-5. PubMed ID: 19506249
[TBL] [Abstract][Full Text] [Related]
13. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.
Watters TM; Kenny EF; O'Neill LA
Immunol Cell Biol; 2007; 85(6):411-9. PubMed ID: 17667936
[TBL] [Abstract][Full Text] [Related]
14. A putative Toll/interleukin-1 receptor domain protein from Helicobacter pylori is dimeric in solution and interacts with human Toll-like receptor adaptor myeloid differentiation primary response 88.
Kaplan-Türköz B
Microbiol Immunol; 2017 Feb; 61(2):85-91. PubMed ID: 28261862
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Toll-interleukin 1 receptor mediated signaling.
Li X; Qin J
J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification, and crystallization of Toll/interleukin-1 receptor (TIR) domains.
Tao X; Tong L
Methods Mol Biol; 2009; 517():81-8. PubMed ID: 19378015
[TBL] [Abstract][Full Text] [Related]
18. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.
Qin J; Qian Y; Yao J; Grace C; Li X
J Biol Chem; 2005 Jul; 280(26):25233-41. PubMed ID: 15866876
[TBL] [Abstract][Full Text] [Related]
19. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N
PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567
[TBL] [Abstract][Full Text] [Related]
20. Identification of interaction sites for dimerization and adapter recruitment in Toll/interleukin-1 receptor (TIR) domain of Toll-like receptor 4.
Bovijn C; Ulrichts P; De Smet AS; Catteeuw D; Beyaert R; Tavernier J; Peelman F
J Biol Chem; 2012 Feb; 287(6):4088-98. PubMed ID: 22139835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
